在震治疗中的技巧和技巧
Franziska Hopfner1, Carsten Buhmann2, Joseph Classen3
1Department of Neurology, Neurologische Klinik und Poliklinik mit Friedrich Baur Institut, Ludwig-Maximilians University, Campus Großhadern, Marchioninistraße 15, 81377, Munich, Germany. franziska.hopfner@med.uni-muenchen.de.
Journal of neural transmission (Vienna, Austria : 1996)
|July 23, 2024
概括
有效的震管理涉及针对各种原因的量身定制策略,包括帕金森病和基本震. 治疗范围从利沃多巴和普拉诺洛尔等药物到先进疗法和非药物干预来改善生活质量.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 生物医学工程 生物医学工程
背景情况:
- 震显著影响患者的生活质量,需要有效的治疗算法.
- 的各种病因,包括神经疾病,其他疾病和药物副作用,存在复杂的管理挑战.
研究的目的:
- 审查当前各种类型的治疗策略.
- 强调个性化管理方法的重要性,考虑到患者的需求和耐受性.
主要方法:
- 对药理疗法的审查:莱沃多巴,多巴胺激动剂,普拉诺洛尔,普里米,抗胆固醇药物,克洛扎平,1-奥克塔诺尔和抗药物.
- 探索先进疗法:对抗性病例进行深度大脑刺激和聚焦超声波.
- 包括非药物干预措施:基于传感器的检测,腕带和物理治疗.
主要成果:
- 利沃多巴是帕金森病震的关键,具有可变的反应.
- 普罗巴诺洛尔是有效的基本震 (ET/ET+),有时与原.
- 备用药物和先进疗法针对特定或耐药的震类型.
- 药物评估至关重要,特别是对于药物诱导的震.
结论:
- 最佳的震管理需要整合药理学,非侵入性和技术方法.
- 考虑到患者特定因素的量身定制策略对于症状控制和改善生活质量至关重要.
- 新兴的基于传感器和非药物干预措施为震护理提供了有希望的未来改进.
相关概念视频
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512
Skeletal Muscle Relaxants: Therapeutic Uses
478
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
478
Centrally Acting Muscle Relaxants: Therapeutic Uses
654
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
654


